Cardiovascular risk and metabolic profile of Polish citizens from Lower Silesia. First signs of metabolic crisis?
- PMID: 35591838
- PMCID: PMC9102627
- DOI: 10.5114/aoms.2020.99922
Cardiovascular risk and metabolic profile of Polish citizens from Lower Silesia. First signs of metabolic crisis?
Abstract
Introduction: Population biobanks are essential for the development of public health screening and improvement of personalized medicine. Since 2012, Biobank of Łukasiewicz Research Network - PORT Polish Center for Technology Development (PORT Biobank) has collected more than 120 000 biological samples from nearly 5000 inhabitants of Lower Silesia, together with a variety of demographic, anthropometric, life style and health information.
Material and methods: The analyzed group consisted of 2274 participants (1398 women, 876 men). Both women and men were further subdivided into five age decades (20+, 30+, 40+, 50+, 60+). For this study, the level of lipids (total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglycerides) was estimated and correlated with the level of high-sensitivity C-reactive protein (hs-CRP) and biometric parameters.
Results: We have demonstrated for the first time that biochemical changes that may lead to cardiovascular diseases (CVD) occurred already in the group of people aged 30+. Our observation is based on measurements of lipids, glucose, inflammatory (hs-CRP) and biometric markers such as body mass index (BMI) and waist-to-hip ratio (WHR).
Conclusions: Positive correlations with age for these variables suggest the ongoing progress of metabolic changes, which in the end may lead to a fatal outcome such as myocardial infarction or stroke. It suggests that CVD screening programs should be dedicated to a wider group, especially younger citizens, in order to prevent fatal outcomes related to CVD.
Keywords: biobanking; cardiovascular diseases; metabolic crisis; population-based screening.
Copyright: © 2020 Termedia & Banach.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.Arch Gynecol Obstet. 2010 Jun;281(6):1009-14. doi: 10.1007/s00404-009-1226-6. Epub 2009 Sep 22. Arch Gynecol Obstet. 2010. PMID: 19771438
-
Classical and emergent cardiovascular disease risk factors in type 2 diabetics from the Vallecas area (DICARIVA study).Nutr Hosp. 2017 Nov 17;34(5):1432-1441. doi: 10.20960/nh.1425. Nutr Hosp. 2017. PMID: 29280661 English.
-
Associations between Body Composition Indices and Metabolic Disorders in Chinese Adults: A Cross-Sectional Observational Study.Chin Med J (Engl). 2018 Feb 20;131(4):379-388. doi: 10.4103/0366-6999.225059. Chin Med J (Engl). 2018. PMID: 29451141 Free PMC article.
-
[Relationship between serum high-sensitivity C-reactive protein and obesity and impaired glycose metabolism in children and adolescents].Zhonghua Er Ke Za Zhi. 2006 Dec;44(12):933-6. Zhonghua Er Ke Za Zhi. 2006. PMID: 17254464 Chinese.
-
Gender differences in cardiovascular risk factors in obese, nondiabetic first degree relatives of African Americans with type 2 diabetes mellitus.Ethn Dis. 1998 Autumn;8(3):319-30. Ethn Dis. 1998. PMID: 9926902
Cited by
-
2023: The year in cardiovascular disease - the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?Arch Med Sci. 2023 Nov 2;19(6):1602-1615. doi: 10.5114/aoms/174743. eCollection 2023. Arch Med Sci. 2023. PMID: 38058712 Free PMC article.
-
Role of atrial natriuretic peptide receptor in inhibition of laterally spreading tumors via Wnt/β-catenin signaling.Arch Med Sci Atheroscler Dis. 2022 Aug 8;7:e104-e108. doi: 10.5114/amsad/151928. eCollection 2022. Arch Med Sci Atheroscler Dis. 2022. PMID: 36158061 Free PMC article.
References
-
- Sigurdardottir FD, Lyngbakken MN, Holmen OL, et al. . Relative prognostic value of cardiac troponin I and C-reactive protein in the general population (from the Nord-Trondelag Health [HUNT] Study). Am J Cardiol 2018; 121: 949-55. - PubMed
-
- Berkelmans GFN, Gudbjörnsdottir S, Visseren FLJ, et al. . Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with type 2 diabetes mellitus. Eur Heart J 2019; 40: 2899-906. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous